Gainers
- Celularity CELU shares rose 7.0% to $7.33 during Tuesday's after-market session. The market value of their outstanding shares is at $904.9 million.
- Tilray TLRY stock moved upwards by 4.87% to $13.76. Trading volume for this security closed at 1.8 million, accounting for 7.66% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.1 billion.
- Vivos Therapeutics VVOS shares increased by 4.6% to $3.52. Today's trading volume for this security ended up closing at 50.0K shares, which is 15.03 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $80.2 million. As per the press release, Q2 earnings came out 3 days ago.
- Cano Health CANO shares moved upwards by 4.04% to $10.04. This security traded at a volume of 421.2K shares come close, making up 20.39% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion. The company's, Q2 earnings came out 3 days ago.
- AzurRx BioPharma AZRX shares rose 3.37% to $0.55. The market value of their outstanding shares is at $50.8 million. As per the press release, Q2 earnings came out yesterday.
- TherapeuticsMD TXMD stock rose 2.98% to $0.79. The market value of their outstanding shares is at $334.8 million.
Losers
- NeuroBo Pharmaceuticals NRBO stock decreased by 5.79% to $3.42 during Tuesday's after-market session. The company's market cap stands at $76.2 million. The company's, Q2 earnings came out yesterday.
- Regulus Therapeutics RGLS shares declined by 3.73% to $0.62. The company's market cap stands at $54.4 million.
- Avrobio AVRO stock declined by 3.41% to $5.96. The market value of their outstanding shares is at $259.9 million.
- Graybug Vision GRAY shares declined by 2.73% to $3.57. The company's market cap stands at $75.9 million. As per the news, the Q2 earnings report came out 4 days ago.
- Altimmune ALT stock fell 2.49% to $11.75. Altimmune's trading volume hit 88.3K shares by close, accounting for 4.57% of its average volume over the last 100 days. The market value of their outstanding shares is at $466.5 million.
- Exelixis EXEL stock declined by 2.48% to $18.53. The market value of their outstanding shares is at $5.8 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in